Vilardell M - Search Results

1

Lack of association between the corticotropin-releasing hormone locus and rheumatoid arthritis.

Julià A, Gallardo D, Vidal F, Tomàs C, Barceló P, Vilardell M, Marsal S. Julià A, et al. Among authors: vilardell m. Arthritis Rheum. 2004 Aug;50(8):2706-8. doi: 10.1002/art.20377. Arthritis Rheum. 2004. PMID: 15334487 Free article. No abstract available.

2

Association of HLA class II genes with systemic sclerosis in Spanish patients.

Simeón CP, Fonollosa V, Tolosa C, Palou E, Selva A, Solans R, Armadans L, Moreno E, Marsal S, Vilardell M. Simeón CP, et al. Among authors: vilardell m. J Rheumatol. 2009 Dec;36(12):2733-6. doi: 10.3899/jrheum.090377. Epub 2009 Nov 2. J Rheumatol. 2009. PMID: 19884273

3

[Usefulness of oral pilocarpin therapy in the treatment of xerostomia and xerophthalmia in patients with primary Sjögren's syndrome].

Solans R, Bosch JA, Selva A, Simeón CP, Fonollosa V, Vilardell M. Solans R, et al. Among authors: vilardell m. Med Clin (Barc). 2004 Feb 28;122(7):253-5. doi: 10.1016/s0025-7753(04)75314-2. Med Clin (Barc). 2004. PMID: 15012873 Spanish.

4

Panniculitis: a cutaneous manifestation of dermatomyositis.

Solans R, Cortés J, Selva A, Garcia-Patos V, Jimenez FJ, Pascual C, Bosch J, Vilardell M. Solans R, et al. Among authors: vilardell m. J Am Acad Dermatol. 2002 May;46(5 Suppl):S148-50. doi: 10.1067/mjd.2002.107491. J Am Acad Dermatol. 2002. PMID: 12004297 Review.

5

Efficacy of cyclophospamide in the treatment of interstitial lung disease associated with systemic sclerosis.

Espinosa G, Simeón CP, Plasín MÁ, Xaubet A, Muñoz X, Fonollosa V, Cervera R, Vilardell M. Espinosa G, et al. Among authors: vilardell m. Arch Bronconeumol. 2011 May;47(5):239-45. doi: 10.1016/j.arbres.2011.01.010. Epub 2011 Mar 31. Arch Bronconeumol. 2011. PMID: 21458128 English, Spanish.

6

[Prospective multicenter study of adverse drug reactions in hospitalized elderly patients].

Vilà A, San José A, Roure C, Armadans L, Vilardell M; Grupo para el estudio de las Reacciones Adversas a Medicamentos en pacientes mayores hospitalizados. Vilà A, et al. Among authors: vilardell m. Med Clin (Barc). 2003 May 3;120(16):613-8. doi: 10.1016/s0025-7753(03)73788-9. Med Clin (Barc). 2003. PMID: 12732126 Spanish.

7

Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial.

Cobo E, Cortés J, Ribera JM, Cardellach F, Selva-O'Callaghan A, Kostov B, García L, Cirugeda L, Altman DG, González JA, Sànchez JA, Miras F, Urrutia A, Fonollosa V, Rey-Joly C, Vilardell M. Cobo E, et al. Among authors: vilardell m. BMJ. 2011 Nov 22;343:d6783. doi: 10.1136/bmj.d6783. BMJ. 2011. PMID: 22108262 Free PMC article. Clinical Trial.

8

Protein Z levels and anti-protein Z antibodies in patients with arterial and venous thrombosis.

Pardos-Gea J, Ordi-Ros J, Serrano S, Balada E, Nicolau I, Vilardell M. Pardos-Gea J, et al. Among authors: vilardell m. Thromb Res. 2008;121(6):727-34. doi: 10.1016/j.thromres.2007.07.009. Epub 2007 Sep 14. Thromb Res. 2008. PMID: 17869328

9

[Training doctors for the future: A review 10 years later].

Cardellach F, Vilardell M, Pujol R. Cardellach F, et al. Among authors: vilardell m. Med Clin (Barc). 2016 Oct 7;147(7):313-5. doi: 10.1016/j.medcli.2016.02.024. Epub 2016 Mar 28. Med Clin (Barc). 2016. PMID: 27033432 Spanish. No abstract available.

10

Acquired haemophilia A: successful treatment with immunosuppression, methylprednisolone pulses and oral cyclosporin.

Pardos-Gea J, Ordi-Ros J, Altisent C, Balada E, Pérez-López J, Vilardell M. Pardos-Gea J, et al. Among authors: vilardell m. Thromb Haemost. 2006 Apr;95(4):735-7. Thromb Haemost. 2006. PMID: 16601847 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

214 results

Search Page